Catalyst Capital Advisors’s Notable Labs, Ltd. Ordinary Shares NTBL Stock Holding History

Catalyst Capital Advisors’s Portfolio NTBL Stock Details NTBL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-224	Closed	-$41K	–	571
2015 Q1	$41K	Buy	+224	New	+$66.1K	﹤0.01%	341

Other funds holding NTBL

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

FTI

Fiduciary Trust International Lincoln, Massachusetts $610M AUM 18.04% 1-Year Est. Return

BWA

Burt Wealth Advisors North Bethesda, Maryland $407M AUM 11.98% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Catalyst Capital Advisors's NTBL Position: Q2 2015 in Review

Catalyst Capital Advisors sold out of Notable Labs, Ltd. Ordinary Shares (NTBL) in Q2 2015, closing a stake of 224 shares — an estimated $41K sold.

Catalyst Capital Advisors first reported a position in NTBL in Q1 2015 and held it in 1 quarter. The position peaked at $41K in Q1 2015. 6 funds tracked by Wall St. Rank hold NTBL as of Q2 2015.

Catalyst Capital Advisors reported no remaining Notable Labs, Ltd. Ordinary Shares position as of Q2 2015 after selling out during the quarter.
Catalyst Capital Advisors sold 224 Notable Labs, Ltd. Ordinary Shares shares in Q2 2015, an estimated $41K.
Catalyst Capital Advisors first reported a position in Notable Labs, Ltd. Ordinary Shares in Q1 2015 and held it in 1 quarter.
Catalyst Capital Advisors's Notable Labs, Ltd. Ordinary Shares position peaked at $41K in Q1 2015.
6 funds tracked by Wall St. Rank held Notable Labs, Ltd. Ordinary Shares as of Q2 2015.

Based on Catalyst Capital Advisors's 13F filing for Q2 2015, filed 12 Aug 2015.